A Clinical Study on the Safety, Efficacy, and Pharmacokinetics of STR-P004 for the Treatment of Immune-Mediated Kidney Diseases
Latest Information Update: 02 Feb 2026
At a glance
- Drugs STR P004 (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
- Sponsors Starna Therapeutics
Most Recent Events
- 02 Feb 2026 New trial record